H1 antagonists: receptor affinity versus selectivity.
Gillard
M
M
UCB Pharma Sector, In Vitro Pharmacology, Chemin Du Foriest, 1420 Braine l'Alleud, Belgium. michel.gillard@ucb-group.com
Christophe
B
B
Wels
B
B
Peck
M
M
Massingham
R
R
Chatelain
P
P
D000818:Animals; D001667:Binding, Competitive; D003001:Cloning, Molecular; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects / Q000378:metabolism; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D043585:Receptor, Muscarinic M2 / Q000187:drug effects; D043587:Receptor, Muscarinic M3 / Q000187:drug effects; D011969:Receptors, Histamine H1 / Q000187:drug effects / Q000378:metabolism*; D011976:Receptors, Muscarinic / Q000187:drug effects / Q000378:metabolism; D014132:Trachea / Q000187:drug effects
D006634:Histamine H1 Antagonists; D043585:Receptor, Muscarinic M2; D043587:Receptor, Muscarinic M3; D011969:Receptors, Histamine H1; D011976:Receptors, Muscarinic